Dr. Reddy’s Laboratories Announces the Acquisition of an Injectable Product Portfolio from Eton Pharma
HYDERABAD, India & PRINCETON, N.J.--(BUSINESS WIRE)--$RDY #Acquisition--Dr. Reddy’s Laboratories Ltd. (BSE: 500124, NSE: DRREDDY, NYSE:…
HYDERABAD, India & PRINCETON, N.J.--(BUSINESS WIRE)--$RDY #Acquisition--Dr. Reddy’s Laboratories Ltd. (BSE: 500124, NSE: DRREDDY, NYSE:…
This award spotlights successful and innovative transformation projects that deliver bottom-line value to small, medium,…
Company Filed a Definitive Information Statement Under Section 14C of the Exchange Act MELBOURNE, Australia--(BUSINESS…
Transaction Expected to Close on July 6, 2022 BILLERICA, Mass. & AURORA, Ill.--(BUSINESS WIRE)--Entegris, Inc.…
Acumen Research and Consulting recently published report titled “mTOR Inhibitors Market Size, Share, Analysis Report…
Results of 100 subjects bridging study and 1,500 subjects placebo-controlled trial of Akston’s AKS-452 announced.…
Results of 100 subjects bridging study and 1,500 subjects placebo-controlled trial of Akston’s AKS-452 announced.…
DUBLIN--(BUSINESS WIRE)--The "Thailand - Telecoms, Mobile and Broadband - Statistics and Analyses" report has been…
DUBLIN--(BUSINESS WIRE)--The "Thailand - Telecoms, Mobile and Broadband - Statistics and Analyses" report has been…
HONG KONG--(BUSINESS WIRE)--Guotai Junan International Holdings Limited ("GTJAI" or the "Company", Stock Code: 1788.HK) announced…